NEW YORK (GenomeWeb) Canadian life sciences firm DiagnoCure announced today that its board has approved a plan to voluntarily dissolve the company and liquidate its assets.
“The board of directors of DiagnoCure has determined that the liquidation and dissolution is advisable and in the best interest of the corporation and its shareholders,” DiagnoCure Chairman Jacques Simoneau said in a statement.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Already have an account?
.
Read the full article at: https://www.genomeweb.com/molecular-diagnostics/diagnocure-board-votes-liquidate-dissolve-company